FDA OKs expanded HeartMate III trial for Thoratec – MassDevice

Thoratec (NSDQ:THOR) today said the FDA approved an expansion of the clinical trial for its next-generation implantable heart pump, the HeartMate III, after evaluating the safety data from 10 initial patients.